MedPath

Effect of prophylactic iron supplementation on Pregnancy outcome

Not Applicable
Conditions
Iron supplementation in pregnant women.
Registration Number
IRCT138706141196N1
Lead Sponsor
lorestan university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
166
Inclusion Criteria

inclusion criteria: GA: <20 weeks, Age:18-24 y,gravidity 1, BMI:18.5-24.9 kg/m2, Hb>110g/l, Serum Ferritin >20Ug/l
Exclusion criteria: Hb<110g/l, infection, disease,

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum ferritin. Timepoint: biggining the study(<20 wk), 28 wk of gestation and 38 wk of gestation. Method of measurement: radioimiunoassay method.;Hemoglobin. Timepoint: biggining the study(<20 wk), 28 wk of gestation and 38 wk of gestation. Method of measurement: cyanid hemoglobin.;Fasting blood sugar. Timepoint: biggining the study(<20 wk), 28 wk of gestation and 38 wk of gestation. Method of measurement: Glocose oxidaze.;Birth weight. Timepoint: at birthday. Method of measurement: recording weight by scale.;Birth length. Timepoint: at birthday. Method of measurement: strip meter.;Gestational age. Timepoint: at birthday. Method of measurement: calculated from the number of completed weeks since the first day of the mother's last menstrual period to the date of birth.
Secondary Outcome Measures
NameTimeMethod
Maternal weight gain. Timepoint: at delivery. Method of measurement: The difference between mothers' weight before pregnancy and after delivery.;Adherence to iron supplementation. Timepoint: at each return visiting by physician. Method of measurement: calculated on the basis of the number of tablets remaining in the box.
© Copyright 2025. All Rights Reserved by MedPath